Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KLF3 pseudogene 2 (KLF3P2) is classified as a pseudogene related to the KLF3 gene, which encodes a transcription factor involved in various biological processes[4]. Pseudogenes like KLF3P2 are generally noncoding remnants of once-functional genes and do not produce functional proteins. No literature, biological function, drug targeting, or disease association has been described for KLF3P2. It should not be considered a therapeutic target. KLF3 itself (not KLF3P2) is a functional transcriptional repressor involved in gene expression regulation, important in processes such as erythropoiesis, metabolism, cardiac development, and immune cell differentiation[1][4]. However, KLF3P2 is distinct from KLF3 and does not encode an active protein[4]. No interacting drugs, therapeutic mechanisms, biomarker roles, or notable safety/therapeutic concerns are associated with KLF3 pseudogene 2. It is not a validated molecular target. KLF3P2 is a pseudogene and not a druggable receptor or therapeutic target. There is no evidence it plays a role in biology, disease, or therapy. If you intended to refer to KLF3 (Kruppel-like factor 3)—a real transcription factor with physiological significance and disease relevance—please clarify, as KLF3 itself is a valid target with a well-established molecular profile[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KLF3 pseudogene 2 (KLF3P2).